Clinical studies have consistently implicated abnormalities in the regulation of key neuroendocrine responses to stress in a proportion of patients with depression, with a hyperactivity of the HPA axis that is probably driven by hypersecretion of the hypothalamic peptide corticotropine releasing hormone (CRH) [5], [6]. The gene discussed is CRH; the disease is major depressive disorder.